Tower Research Capital (TRC)’s 4D Pharma PLC LBPS Stock Holding History

Tower Research Capital (TRC)’s Portfolio LBPS Stock Details LBPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,643	Closed	–	–	6947
2022 Q3	$0	Hold	4,643	–	–	﹤0.01%	6973
2022 Q2	$8K	Sell	4,643 -3,863	-45%	-$13.1K	﹤0.01%	4748
2022 Q1	$41K	Buy	+8,506	New	+$35.5K	﹤0.01%	2893
2021 Q2	–	Sell	-8	Closed	–	–	6156
2021 Q1	$0	Buy	+8	New	+$100	﹤0.01%	5928

Tower Research Capital (TRC)'s LBPS Position: Q4 2022 in Review

Tower Research Capital (TRC) sold out of 4D Pharma PLC (LBPS) in Q4 2022, closing a stake of 4,643 shares.

Tower Research Capital (TRC) first reported a position in LBPS in Q1 2021 and held it in 4 quarters. The position peaked at $41K in Q1 2022. 1 fund tracked by Wall St. Rank holds LBPS as of Q4 2022.

Tower Research Capital (TRC) reported no remaining 4D Pharma PLC position as of Q4 2022 after selling out during the quarter.
Tower Research Capital (TRC) sold 4,643 4D Pharma PLC shares in Q4 2022.
Tower Research Capital (TRC) first reported a position in 4D Pharma PLC in Q1 2021 and held it in 4 quarters.
Tower Research Capital (TRC)'s 4D Pharma PLC position peaked at $41K in Q1 2022.
1 fund tracked by Wall St. Rank held 4D Pharma PLC as of Q4 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.